Postoperative chemoradiotherapy in patients with locally advanced gastric cancer with poor pathologic response to neoadjuvant chemotherapy.

Autor: Gal O; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel., Lewin R; Chaim Sheba Medical Center, Tel Hashomer, Israel., Perl G; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel., Ulitzky O; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel., Brenner B; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Kundel Y; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Publikováno v: Journal of cancer research and therapeutics [J Cancer Res Ther] 2024 Jan 01; Vol. 20 (1), pp. 281-284. Date of Electronic Publication: 2023 Apr 07.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Young patients and gastrointestinal (GI) tract malignancies - are we addressing the unmet needs?

Autor: Perl, G.¹, Nordheimer, S.¹, Lando, S.², Benedict, C.³, Brenner, B.^1,2, Perry, S.^1,2, Shmoisman, G.¹, Purim, O.¹, Amit, L.¹, Stemmer, S. M.^1,2, Ben-Aharon, I.^1,2

Publikováno v: BMC Cancer. 8/12/2016, Vol. 16, p1-8. 8p. 1 Chart, 3 Graphs.

P-81 Phase 3 study of MK4280A (coformulated favezelimab and pembrolizumab) versus standard of care in previously treated PD-L1–positive metastatic colorectal cancer (mCRC)

Autor: Kim, T., Taieb, J., Passhak, M., Kim, S., Geva, R., Hofsli, E., Perl, G., Yalcin, S., Hubert, A., Somer, B., Wong, Z., Wang, A., Leconte, P., Fogelman, D., Heinemann, V.

Publikováno v: In Annals of Oncology June 2022 33 Supplement 4:S277-S277

Signet Ring Cell Features are Associated with Poor Response to Neoadjuvant Treatment and Dismal Survival in Patients with High-Grade Esophageal Adenocarcinoma.

Autor: Solomon D; Department of Surgery, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Abbas M; Department of Surgery, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Feferman Y; Department of Surgery, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Haddad R; Department of Surgery, Carmel Carmel Medical Center, Affiliated with the Rappaport Faculty of Medicine, Technion, Haifa, Israel., Perl G; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Kundel Y; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Morgenstern S; Department of Pathology, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Menasherov N; Department of Surgery, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Kashtan H; Department of Surgery, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel. hkashtan@clalit.org.il.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. hkashtan@clalit.org.il.

Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2021 Sep; Vol. 28 (9), pp. 4929-4940. Date of Electronic Publication: 2021 Mar 11.